Nano Matters

Spinal cord stimulators are a promising approach to treating pain and spinal cord injuries. In this episode of Nano Matters, Dr. Angelique Johnson, CEO of MEMStim LLC, describes her work on developing new types of spinal cord stimulators using nanotechnology.

If you would like to learn more about nanotechnology, go to nano.gov or email us at [email protected].

Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/MI7J8-utHv8

CREDITS

Special thanks to:

Dr. Angelique Johnson

MEMStim, LLC

Music:

Inspirational Outlook by Scott Holmes

https://www.freemusicarchive.org/music/Scott_Holmes/Inspiring__Upbeat_Music/Scott_Holmes_-_Inspirational_Outlook

https://creativecommons.org/licenses/by-nc/4.0/legalcode

Produced by:

Mallory Hinks, Ph.D.

AAAS S&T Policy Fellow at NNCO

Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.

Have you ever wondered where scientists come up with their ideas? In this episode of Nano Matters, our guest, Professor LaShanda Korley, from the University of Delaware, describes her research on smart materials, which was inspired by a marine worm.

If you would like to learn more about nanotechnology, go to nano.gov or email us at [email protected].

Closed captioning is available on our YouTube channel. For this episode, go to: https://youtu.be/pnFHoSHKs-o

CREDITS

Special thanks to:

Professor LaShanda Korley

University of Delaware

Music:

Inspirational Outlook by Scott Holmes

https://www.freemusicarchive.org/music/Scott_Holmes/Inspiring__Upbeat_Music/Scott_Holmes_-_Inspirational_Outlook

https://creativecommons.org/licenses/by-nc/4.0/legalcode

Produced by:

Dr. Mallory Hinks

AAAS S&T Policy Fellow at NNCO

Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.

In this episode, we discuss how nanotechnology can be applied to treat cancer. Our guest, Chad Mirkin of Northwestern University, and his colleagues, have developed a cancer therapy that is fueled by nanotechnology. Their technique activates the immune system in a unique way to fight diseases like cancer.

This is the first episode of the Nano Matters podcast! Stay tuned for more episodes.

If you would like to learn more about nanotechnology, go to nano.gov or email us at [email protected].

Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/uaqlOj_5m7w

CREDITS

Special thanks to:

Chad Mirkin

Northwestern University

Music:

Inspirational Outlook by Scott Holmes

https://www.freemusicarchive.org/music/Scott_Holmes/Inspiring__Upbeat_Music/Scott_Holmes_-_Inspirational_Outlook

https://creativecommons.org/licenses/by-nc/4.0/legalcode

Produced by:

Dr. Mallory Hinks

AAAS S&T Policy Fellow at NNCO

Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.